Two tiers of biomedicalization: METHADONE buprenorphine and the racial politics of addiction treatment

Advances in Medical Sociology

Volumn 14, Issue , 2012, Pages 79-102

  Hansen, Helena ^a   Roberts, Samuel K ^a  

^a NONE

Author keywords

Biomedicalization; Buprenorphine treatment; Medicalization; Methadone maintenance; Opiate addiction; Race

Indexed keywords

EID: 84886444681     PISSN: 10576290     EISSN: None     Source Type: Book Series    
DOI: 10.1108/S1057-6290(2012)0000014008     Document Type: Article

References (77)

1. A reclassification for methadone.1972 Science News 101(15) 229.
2. Acker C. J.2002 Creating the American Junkie: Addiction research in the classic era of narcotic control. Baltimore MA: Johns Hopkins University Press.
3. Agar M. Bourgois P. French J. & Murdoch O.2001 Buprenorphine: 'Field trials' of a new drug. Qualitative Health Research 11(1) 69-84.
4. Arnold M.1965 Narcotics a growing problem of affluent youth. New York Times January 4.
5. Bayer R.1976 Heroin maintenance: An historical perspective on the exhaustion of liberal narcotics reform. Journal of Psychedelic Drugs 8(2) 157-165.
6. Bell J. R. Butler B. Lawrence A. Batey R. & Salmelainen P.2009 Comparing overdose mortality associated with methadone and buprenorphine. Drug and Alcohol Dependence 104(1-2) 73-77.
7. Bellis D. J.1981 Heroin and politicians: The failure of public policy to control addiction in America. Westport CT: Greenwood Press.
8. Biondi M.2003 To stand and fight: The struggle for civil rights in postwar New York City. Cambridge: Harvard University Press.
9. Brunswick A. F.1977 Health and drug behavior: A study of urban black adolescents. Addictive Diseases 3(2) 197-214.
10. Brunswick A. F.1979 Black youths and drug-use behavior. In G. M. Beschner & A. S. FriedmanEds.) Youth drug abuse: Problems issues and treatment. Lexington MA: Lexington Books.
11. Brunswick A. F.1980 Social meanings and developmental needs: Perspectives on black youth's drug abuse. Youth & Society 11(4) 449-473.
12. Brunswick A. F.1988 Young black males and substance abuse. In J. T. GibbsEd.) Young black and male in America: An endangered speciespp. 166-187 Dover MA: Auburn House Publishing Company.
13. Butler S. Black R. Cassidy T. Daily T. & Simon B.2011 Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduction Journal 8 29. Retrieved from http://www. harmreductionjournal.com/ content/8/1/29. Accessed on January 30 2012.
14. Campbell N.2010 Toward a critical neuroscience of addiction. BioSocieties 5 89-104.
15. Campbell N.2012 Medicalization and biomedicalization: Does the diseasing of addiction fit the frame? In J. NetherlandEd.) Critical perspectives on addictionVol. 14 Advances in medical anthropology. Bingley: Emerald.
16. Campbell N. D.2007 Discovering addiction: The science and politics of substance abuse research. Ann Arbor MI: University of Michigan Press.
17. Cannato V. J.2001 The ungovernable city: John Lindsay and his struggle to save New York. New York NY: Basic Books.
18. Cicero T. J. Inciardi J. A. & Munoz A.2005 Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. Journal of Pain 6(10) 662-672. (Pubitemid 41395058)
19. Clarke A. E. Shim J. K. Mamo L. Fosket J. R. & Fishman J. R.2003 Biomedicalization: Technoscientific transformations of health illness and U.S. biomedicine. American Sociological Review 68(2) 161-194. (Pubitemid 36696071)
20. CNNCable News Network Rush Limbaugh admits addiction to pain medication. CNN Entertainment October 10 2003. Retrieved from http://articles.cnn.com/2003- 10-10/ entertainment/rush.limbaugh-1-wilma-cline-rush-limbaugh-inaccuracies-and- distortions?-sPM:SHOWBIZ. Accessed on January 6 2012.
21. Conditions for investigational use of methadone for maintenance programs for narcotic addicts.1970 Federal Register 35(113) pp. 9014-9016.
22. Conrad P.2005 The shifting engines of medicalization. Journal of Health and Social Behavior 46(1) 3-14. (Pubitemid 41503889)
23. Courtwright D. Joseph H. & Des Jarlais D.1989 Addicts who survived: An oral history of narcotic use in America 1923-19651st ed Knoxville TN: University of Tennessee Press.
24. Crime in the National Capital. Part 2: Narcotics-Crime Crisis in the Washington Area. Hearings Before the United States Senate Committee on the District of Columbia United States Senate Committee on the District of Columbia 1 Sess.1969
25. Drug Addict Treatment and Rehabilitation Act of 1972 - Hearings Before the U.S. Senate Subcommittee on Alcoholism and Narcotics of the Senate Committee on Labor and Public Welfare1972
26. Edwards C. C.1972 Approved new drugs requiring continuation of long-term studies records and reports; listing of methadone with special requirements for use. Federal Register 37(242) 26790-26806.
27. Epstein E. J.1974 December War of the poppies. Esquire.
28. Epstein E. J.1975 The Krogh file-The politics of 'Law and Order'. Public Interest 39 99-124.
29. Etzioni A. & Remp R.1972 Technological 'shortcuts' to social change. Source Science 175(4017) 31-37.
30. Farrell W. E.1965 City backs plan to cure addicts. New York Times June 8.
31. Folsom M.1964 Teen-age addicts a Yonkers worry. New York Times p. 1 August 20.
32. Glenn J. E.2005 Medicalizing addictions criminalizing addicts: race politics and profit in narratives of addiction. Unpublished doctoral dissertation Harvard University Cambridge MA.
33. Gollance H.1970 Methadone maintenance treatment program. Maryland State Medical Journal 19(11) 74-79.
34. Hamid A. Curtis R. McCoy K. McGuire J. Conde A. Bushell W. et al.1997 The heroin epidemic in New York City: Current status and prognoses. Journal of Psychoactive Drugs 29(4) 375-391. (Pubitemid 28063234)
35. Hannerz U.2004 Soulside: Inquiries into Ghetto Culture and Community. Chicago IL: University of Chicago.
36. HEALTH-PAC Workshop on Drug Addiction Block H. & Wallerstein L.1970 June Who benefits from the American drug culture? HEALTH-PAC Bulletin pp. 1-20.
37. Healy D.2004 Let them Eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York NY: New York University Press.
38. Hickman T. A.2004 The double meaning of addiction: Habitual narcotic use and the logic of professionalizing medical authority in the United States 1900-1920. In S. W. Tracy & C. J. AckerEds.) Altering American consciouness: The history of alcohol and drug use in the United States 1800-2000pp. 182-202 Amherst MA: University of Massachusetts Press.
39. Holden C.1975 Drug abuse 1975: The 'war' is past the problem is as big as ever. Science 190(4215) 638-641.
40. Iiyama P. Nishi S. & Johnson B. D.1976 Drug use and abuse among U.S. minorities: An annotated bibliography. New York NY: Praeger.
41. Jaffe J. & O'Keeffe C.2003 From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States. Drug and Alcohol Dependence 70 S3-S11. (Pubitemid 36556056)
42. Johnson B. D.1977 The race class and irreversibility hypotheses: Myths and research about heroin. In J. D. RittenhouseEd.) The epidemiology of heroin and other narcoticsNIDA research monograph 16)pp. 51-57 Rockville MD: National Institute on Drug Abuse Division of Research.
43. Johnson B. D. & Nishi S.1976 Myths and realities of drug use by minorities. In P. Iiyama S. Nishi & B. D. JohnsonEds.) Drug use and abuse among U.S. minorities: An annotated bibliographypp. 3-68 New York NY: Praeger.
44. Lennard H. L. Epstein L. J. & Rosenthal M. S.1972 The methadone illusion. Science 176(4037) 881884.
45. Link B. & Phelan J.2010 Labeling and stigma. In T. L. Scheid & T. N. BrownEds.) New York NY: Cambridge University Press.
46. Lipson S.2011 20 December Mixed evidence of methadone crackdown: An advocacy group's survey says police harassment of methadone patients is common. Statistics Suggest Methadone-Related Arrests Are Rare. City Limits.
47. Lovell A. M.2006 Addiction markets: The case of high-dose Buprenorphine in France. In A. Petryna A. Lakoff & A. KleinmanEds.) Global pharmaceuticals: Ethics markets practicespp. 136-170 Durham NC: Duke University Press.
48. Mattick R. Breen C. Kimber J. & Marina D.2003 Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Systems Review2) CD002209.
49. McLellan A. T. Lewis D. O'Brien C. & Herbert K.2000 Drug dependence: A chronic mental illness. JAMA 284 1689-1694.
50. Moynihan R. Heath I. & Henry D.2002 Selling sickness: The pharmaceutical industry and disease mongering. BMJ 324(7342) 886-891.
51. Mulvihill D. J. Tumin M. M. Curtis L. A.1969 United States Task Force on Individual Acts of Violence & United States National Commission on the Causes and Prevention of Violence. Crimes of Violence: A Staff Report Submitted to the National Commission on the Causes & Prevention of Violence. Washington DC: Government Printing Office.
52. Musto D. F.1999 The American disease: Origins of narcotic control3rd ed New York NY: Oxford University Press.
53. Musto D. F. & Korsmeyer P.2002 The quest for drug control: Politics and federal policy in a period of increasing substance abuse 1963-1981. New Haven CT: Yale University Press.
54. Nelkin D.1973 Methadone maintenance: A technological fix. New York NY: G. Braziller.
55. Netherland J.2010 Becoming normal: The social construction of buprenorphine and new attempts to medicalize addiction. Dissertation Department of Sociology City University of New York Graduate Center.
56. New York Times.1964 March 2 Queens Boy dies at Heroin Party. New York Times p. 13.
57. NIDANational Institute of Drug Abuse)2011 May Prescription drug abuse: A research update from the National Institute on Drug Abuse. Retrieved from http://drugabuse. gov/tib/prescription.html. Accessed on November 23 2012.
58. Osnos P.1972 December 26 Is it a solution? The Washington Post.
59. Pescosolido B. A. Martin J. K. Long J. S. Medina T. R. Phelan J. C. & Link B. G.2010 'A disease like any other'? A decade of change in public reactions to schizophrenia depression and alcohol dependence. American Journal of Psychiatry 167(11) 1321-1330.
60. Phelan J. & Link B.2012 Genetics addiction and stigma. In A. R. ChapmanEd.) Genetic research on addiction. New York NY: Cambridge University Press.
61. Raspberry W.1971a June 25 Holdups or hangups? The Washington Post.
62. Raspberry W.1971b May 11 Methadone use: Another blunder. The Washington Post.
63. Reckitt Benckiser Pharmaceuticals.2009 Annual Report 2009. Retrieved from http:// annualreport2009.rb.com/Home. Accessed on April 28 2012.
64. Reckitt Benckiser Pharmaceuticals. Annual Report 2010. Retrieved from http://www.rb.com/ Investor-information/Investor-information/Online-Annual- Report-2010. Accessed on April 28 2012.
65. Roberts S.2009 Infectious fear: Politics disease and the health effects of segregation. Chapel Hill NC: University of North Carolina Press.
66. Roberts S.2012 forthcoming 'Rehabilitation' as boundary object: Medicalization local activism and narcotics addiction policy in New York City 1951-1962. Social History of Alcohol and Drugs 26(2
67. Robins L. N. & Murphy G. E.1967 Drug use in a normal population of young Negro men. American Journal of Public Health 57(9) 1580-1596.
68. SAMHSASubstance Abuse and Mental Health Services Administration2012 Drug Addiction Treatment Act of 2000. Retrieved from http://buprenorphine.samhsa.gov/ data.html. Accessed on May 1 2012.
69. Sees K. L. Delucchi K. L. Masson C. Rosen A. Clark H. W. Robillard H.yHall S. M.2000 Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. JAMA 283(10) 1303- 1310. (Pubitemid 30129797)
70. Schneider E. C.2008 Smack: Heroin and the American City. Philadelphia PA: University of Pennsylvania Press.
71. Stanton A. McLeod C. Luckey B. Kissin W. & Sonnefeld L. J.2006 Expanding treatment of opioid dependence: Initial physician and patient experiences with the adoption of buprenorphine. Retrieved from http://www.buprenorphine.samhsa.gov/ASAM-06- Final-Results.pdf. Accessed on March 10 2010.
72. U.S. FDA2002 Subutex and Suboxone approved to treat opiate dependence. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatients andProviders/ucm191521.htm. Accessed on May 1 2012.
73. Van Zee A.2009 The promotion and marketing of oxycontin: Commercial triumph public health tragedy. American Journal of Public Health 99(2) 221-227.
74. Vocci F. Acri J. & Elkashef A.2005 Medication development for addictive disorders: The state of the science. American Journal of Psychiatry 162 1432-1440. (Pubitemid 41105557)
75. Vrecko S.2010 Birth of a brain disease: Science the state and addiction neuropolitics. History of the Human Sciences 23(4) 52-67.
76. Walsh J.1970 Methadone and heroin addiction: Rehabilitation without a 'cure'. Science 168(3932) 684-686.
77. Yuill K.2009 Another take on the Nixon presidency: The first therapeutic president? Journal of Policy History 21(02) 138-162.